Evaluating nervous system complications from radiotherapy
Official title: An Observational Study in Clinical Manifestations, Therapeutic Effects, Progress, and Prognosis of Radiotherapy-related Nervous System Complications
Run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT03908502 · Data updated 2026-11-12
This study is trying to see how radiotherapy affects the nervous system in patients and what can be done to help them feel better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years and up |
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | June 1, 2017 |
| Main results expected | December 31, 2037 |
| Study ends | December 31, 2037 |
| Registry record updated | July 25, 2023 |
| Trial ID | NCT03908502 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who have received radiotherapy for head and neck tumors or central nervous system cancers.
✕Probably not a fit
Patients who are unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the clinical manifestations and therapeutic effects of nervous system complications arising from radiotherapy. Patients who have received radiotherapy will undergo a series of examinations, including blood tests, imaging studies, and neurological assessments, to monitor their condition and overall survival. The study seeks to understand the progression and prognosis of these complications, which can range from mild to severe neurological defects. Regular follow-ups will help in gathering comprehensive data on the impact of radiotherapy on the nervous system.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients experiencing complications from radiotherapy.
How similar studies have gone: While there have been studies on radiotherapy effects, this specific observational approach to nervous system complications is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Receipt of radiotherapy Exclusion Criteria * Inability to sign a written informed consent.
Where it's running
-
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Yamei Tang, M.D., PhD.
- Email: tangym@mail.sysu.edu.cn
- Phone: 86-13556001992
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
MRG003 added to ongoing treatment after progression in EGFR-positive advanced thyroid cancer
In this study, researchers test whether adding MRG003 to a patient’s current thyroid cancer treatment can shrink tumors for those whose cancer initially responded but later progressed.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
First-line combo therapy with anlotinib, benmelstobart, and HAIC for unresectable HCC
This study tests whether adding benmelstobart and hepatic arterial infusion chemotherapy to anlotinib can help people with unresectable hepatocellular carcinoma respond to treatment as a first line.
-
Culmerciclib with endocrine therapy before surgery for early HER2-negative hormone receptor-positive breast cancer
This trial tests whether adding culmerciclib to an aromatase inhibitor before surgery helps women with certain early breast cancers better shrink tumors than an aromatase inhibitor alone.
-
Optical surface guidance for head and neck radiotherapy with open-face mask
This trial tests whether using optical surface guidance with an open-face mask during radiotherapy for head and neck cancer improves positioning and reduces movement compared with the standard closed mask approach.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.